Article Details

Pfizer vs. Accenture: With Return Forecast Of 23%, Pfizer Is A Better Bet | Trefis

Retrieved on: 2024-04-13 15:31:04

Tags for this article:

Click the tags to see associated articles and topics

Pfizer vs. Accenture: With Return Forecast Of 23%, Pfizer Is A Better Bet | Trefis. View article details on HISWAI: https://www.trefis.com/data/companies/PFE/no-login-required/I50cEr78/Pfizer-vs-Accenture-With-Return-Forecast-Of-23-Pfizer-Is-A-Better-Bet

Excerpt

Pfizer is trading at a cheaper P/S valuation vs. Accenture and it makes sense to pay less for Pfizer for a higher return. PFE and ACN have similar ...

Article found on: www.trefis.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up